Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR,an inhibitory C-type lectin receptor

Dendritic cell immunoreceptor (DCIR) is a C-type lectin receptor containing a carbohydrate recognition domain in its extracellular portion and an immunoreceptor tyrosine–based inhibitory motif, which transduces negative signals into cells, in its cytoplasmic portion. Previously, we showed that Dcir^–/– mice spontaneously develop autoimmune diseases such as enthesitis and sialadenitis due to excess expansion of dendritic cells (DCs), suggesting that DCIR is critically important for the homeostasis of the immune system. In this report, we analyzed the role of DCIR in the development of experimental autoimmune encephalomyelitis (EAE), an autoimmune disease model for multiple sclerosis. We found that EAE was exacerbated in Dcir^–/– mice associated with severe demyelination of the spinal cords. The number of infiltrated CD11c⁺ DCs and CD4⁺ T cells into spinal cords was increased in Dcir^–/– mice. Recall proliferative response of lymph node cells was higher in Dcir^–/– mice compared with wild-type mice. These observations suggest that DCIR is an important negative regulator of the immune system, and Dcir^–/– mice should be useful for analyzing the roles of DCIR in an array of autoimmune diseases.     

Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion

Clec14a is a member of the thrombomodulin (TM) family, but its function has not yet been determined. Here, we report that Clec14a is a plasma membrane protein of endothelial cells (ECs) expressed specifically in the vasculature of mice. Deletion mutant analysis revealed that Clec14a mediates cell–cell adhesion through its C-type lectin-like domain. Knockdown of Clec14a in ECs suppressed cell migratory activity and filopodial protrusion, and delayed formation of tube-like structures. These findings demonstrate that Clec14a is a novel EC-specific protein that appears to play a role in cell–cell adhesion and angiogenesis.     

高通量测序分析实验性脑脊髓炎肠道微生物变化及与IL-17、IFN-γ相关性

【目的】通过建立实验性脑脊髓膜炎（EAE）小鼠模型,观察小鼠肠道菌群在不同发病时间点的变化和炎症因子IL-17、IFN-γ的表达情况,探讨肠道菌群的变化在EAE发病中的免疫调节作用。【方法】将48只C57BL/6小鼠按照随机数字表法分为正常对照组、EAE模型组各24只。EAE组采用MOG35-55与完全弗氏佐剂的混合物制备模型,进行神经功能评分,记录体重变化。分别取免疫后7、14、21、30 d的小鼠粪便,对样本DNA的16S rDNA V3/V4区基因测序。ELASE法检测IL-17、IFN-γ的表达。【结果】EAE组小鼠血液中IL-17、IFN-γ的表达从第7天开始逐渐升高,21 d时达到高峰。14 d时,EAE组与正常对照组相比,物种丰度有显著性差异（P<0.05）的菌种有:Alistipes、布牢特氏菌属、毛螺菌科_NK4A136_group等。30dEAE组与正常对照组相比,物种丰度有显著性差异（P<0.05）的菌种有:Allobaculum、真细菌属、螺杆菌等。通过LefSe分析,在7、14、21 d中分别主要作用的微生物菌种逐渐减少,在21d时最少。Odoribacter在21d时起了主要作用。【结论】与正常对照组相比,14、21、30dEAE小鼠肠道菌种的丰度均发生了变化,产生了肠道菌群的紊乱;其中普雷沃氏菌属_NK3B31_group的丰度均较正常对照组降低,与IFN-γ呈负相关（r=–0.537,P<0.01）。普雷沃氏菌属_NK3B31_group可能是导致MS脱髓鞘发生的关键菌属。EAE组各个时间点相比起主要作用的肠道菌群种类减少,多样性降低。其中,Odoribacter是在21 d高峰期起主要作用的菌种,但其作用机制需要深入研究。EAE组中炎症因子IL-17、IFN-γ表达的升高,促进了MOG35-55诱发的炎症反应。     

C型凝集素

C型凝集素（C-type lectin）代表一个识别碳水化合物配体依赖于钙离子（Ca2＋）参与的糖原结合蛋白家族,含有一个或多个一级结构和二级结构同源的碳水化合物识别结构域。随着研究的深入,越来越多的C型凝集素能够识别体内的非糖类的配体,包括蛋白质和脂类等。这些C型凝集素在维持机体稳态、免疫防御以及免疫监视等重要生理病理过程中发挥着重要作用。就C型凝集素的结构、分类和在免疫系统中的功能作一介绍。     

Pathogenic implications of iron accumulation in multiple sclerosis

Iron, an essential element used for a multitude of biochemical reactions, abnormally accumulates in the CNS of patients with multiple sclerosis (MS). The mechanisms of abnormal iron deposition in MS are not fully understood, nor do we know whether these deposits have adverse consequences, that is, contribute to pathogenesis. With some exceptions, excess levels of iron are represented concomitantly in multiple deep gray matter structures often with bilateral representation, whereas in white matter, pathological iron deposits are usually located at sites of inflammation that are associated with veins. These distinct spatial patterns suggest disparate mechanisms of iron accumulation between these regions. Iron has been postulated to promote disease activity in MS by various means: (i) iron can amplify the activated state of microglia resulting in the increased production of proinflammatory mediators; (ii) excess intracellular iron deposits could promote mitochondria dysfunction; and (iii) improperly managed iron could catalyze the production of damaging reactive oxygen species (ROS). The pathological consequences of abnormal iron deposits may be dependent on the affected brain region and/or accumulation process. Here, we review putative mechanisms of enhanced iron uptake in MS and address the likely roles of iron in the pathogenesis of this disease.     

酵母多糖影响人朗格汉斯细胞C型凝集素受体的研究

探究酵母多糖（Zymosan）对人朗格汉斯细胞（Langerhans cells, LCs）C型凝集素受体（C-type lectin receptors, CLRs）的影响。收集健康志愿者血液样本,Ficoll淋巴细胞分离液分离外周血单个核细胞,CD14磁珠分选CD14⁺细胞,用含有GM-CSF（1 000 U/mL）、IL-4（1 000 U/mL）、TGFβ-1（10 ng/mL）的培养液诱导培养LCs, Zymosan刺激LCs,8、24 h后收集细胞。提取Zymosan实验组和对照组细胞RNA,实时RT PCR分析5种CLRs（Dectin-1、Dectin-2、DC-SIGN、Mincle、MRC-2） mRNA的水平,扩增产物测序鉴定。共检测10个个体来源LCs在酵母多糖刺激后其CLRs mRNA变化的情况。在10组样本中,有6组Dectin 2受体mRNA较对照组增加（变化倍数≥2）,其中3组增加明显（变化倍数≥5）,最大增加倍数为20.91;有5组Mincle受体mRNA较对照组增加（变化倍数≥2）,其中4组增加明显（变化倍数≥5）,最大增加倍数为19.98;有1组MRC-2受体mRNA较对照组明显增加（变化倍数≥5）。Dectin-1和DC-SIGN受体mRNA没有增加。Zymosan能增加部分个体来源LCs内Dectin-2、Mincle和MRC-2受体mRNA的水平,而对Dectin-1和DC-SIGN受体mRNA的水平没有影响。本研究结果完善了Zymosan调节机体免疫功能的作用机制。     

Anti-IL-17A blocking antibody reduces cyclosporin A-induced relapse in experimental autoimmune encephalomyelitis mice

Cyclosporin A (CsA) is effective at reducing pathogenic immune responses, but upon withdrawal of CsA the immune response often “rebounds” resulting in a relapse or exacerbation of disease. The mechanisms, cells and cytokines involved in the relapse or exacerbation after CsA withdrawal are unknown. We hypothesized that CsA withdrawal induces IL-17 production that could be responsible for relapse, and examined the effect of anti-IL-17A antibody on relapse induced after CsA withdrawal in mouse experimental autoimmune encephalomyelitis (EAE). CsA treatment markedly decreased the EAE disease score during the first episode, but augmented disease severity after CsA withdrawal, compared to untreated mice. After discontinuation of CsA the production of IL-17A was increased and the severity of relapse in EAE was reduced by treatment with anti-IL-17A antibody. These results suggest that the resumption of T cell immune responses after CsA withdrawal leads to a burst of IL-17A production that is at least partially responsible for relapse in EAE mice.     

Male sex chromosomal complement exacerbates the pathogenicity of Th17 cells in a chronic model of central nervous system autoimmunity

1. Download : Download high-res image (123KB)
2. Download : Download full-size image

     

Characterization of rat β-glucan receptor dectin-1

Dectin-1 is a small C-type lectin receptor for fungal cell wall β-glucan. Its homologues in some species, including mouse and human, have been characterized, and their importance in antifungal immunity has also been clarified. However, its homologue in the rat has not yet been identified. In this study, DNA/amino acid sequences of rat dectin-1 were analyzed by rapid amplification of cDNA ends. The sequence of rat dectin-1 was found to be highly homologous to that of the mouse. It possesses essential motifs for the recognition of β-glucan and signal transduction. However, the position of the start codon in the detected sequence was not conserved, and its cytoplasmic tail was shorter than that observed in other species. Similar to mouse dectin-1, two major isoforms of rat dectin-1 that were generated by alternative splicing were identified: a full-length isoform and a shorter isoform deficient in the stalk domain. It was also demonstrated that rat dectin-1 is capable of binding fungal β-glucan and activating nuclear factor-kappa B via Syk and the CARD9/Bcl10-mediated pathway. These results suggest that rat dectin-1 also plays essential roles in immune responses against fungi.     

A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelytis

Snu13p is a Saccharomyces cerevisiae protein essential for pre-messenger RNA splicing and pre-ribosomal RNA processing. Snu13p binds U4 snRNA of the spliceosome and box C/D snoRNAs of the pre-ribosomal RNA processing machinery to induce assembly of each ribonucleoprotein complex. Here, we present structural and biochemical analysis of Snu13p. The crystal structure of Snu13p reveals a region of the protein which could be important for protein interaction during ribonucleoprotein assembly. Using the structure of Snu13p we have designed the first temperature-sensitive mutants in Snu13p, L67W and I102A. Wild-type and mutant Snu13p proteins were assayed for binding to U4 snRNA and U3 snoRNA. Both temperature-sensitive mutants displayed significantly reduced RNA binding compared to wild-type protein. As the temperature-sensitive mutations are not in the known RNA binding region of Snu13p this indicates that these mutants indirectly influence the RNA binding properties of Snu13p. This work provides insight into Snu13p function during ribonucleoprotein assembly.     

Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis

Five types of dopamine receptors, termed D1 to D5, have been identified to date. The D1 and D5 receptors form the D1-like group that couples with the Gαs class of G proteins, while D2, D3 and D4 form the D2-like group that couples with the Gαi class of G proteins. A D2-like-receptor (D2-like-R) antagonist L750667 induced dendritic cell (DC)-mediated Th17 differentiation. In contrast, a D1-like-R antagonist SCH23390 inhibited DC-mediated Th17 differentiation. The D1-like-Rs were expressed on both DCs and T cells, whereas D2-like-Rs were marginally expressed on CD4⁺CD45RA⁺ naïve T cells. In addition, SCH23390 had the ability to prevent experimental autoimmune encephalomyelitis (EAE) in mice. Spleen cells from EAE mice showed decreased IL-17 production, when SCH23390 was administered. Adoptive transfer of DCs treated with SCH23390 successfully prevented EAE. These findings indicate that antagonizing D1-like-Rs on DCs inhibits Th17 differentiation, thereby leading to an amelioration of EAE.     

Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?

Our understanding of the pathophysiology of multiple sclerosis (MS) has evolved significantly over the past two decades as the fields of immunology and neurobiology provide new avenues of exploration into the cause and mechanism of the disease. It has been known for decades that T cells have different cytokine phenotypes, yet the cytokine phenotype of pathogenic T cells in MS is still an area of debate. In EAE, it appears that IFNγ and IL-17, produced by Th1 and Th17 cells respectively, are not the critical factor that determines T cell encephalitogenicity. However, there are molecules such as IL-23, T-bet and STAT4, that appear to be critical, yet it is unclear whether all these molecules contribute to a common, yet undefined pathway, or act in a synergistic manner which culminates in encephalitogenicity has still to be determined. Therefore, the focus of research on effector T cells in MS should focus on pathways upstream of the cytokines that define Th1 and Th17 cells, since downstream products, such as IFNγ and IL-17, probably are not critical determinants of whether an effector T cells is capable of trafficking to the CNS and inducing inflammatory demyelination.